Literature DB >> 2991270

Site-specific phosphorylation of avian retrovirus nucleocapsid protein pp12 regulates binding to viral RNA. Evidence for different protein conformations.

X Fu, N Phillips, J Jentoft, P T Tuazon, J A Traugh, J Leis.   

Abstract

Phosphorylation of serine 40 of the major nucleocapsid protein of avian retroviruses, pp12, regulates binding to viral RNA (Leis, J., Johnson, S., Collins, L. S., and Traugh, J. A. (1984) J. Biol. Chem. 259, 7726-7732). The phosphorylation state of the protein can be altered in vitro, resulting in the interconversion of the protein between a state of high affinity for single-stranded RNA and low affinity for single- or double-stranded RNA. The reversible phosphorylation of serine 40 is accompanied by a change in the conformation of the protein as demonstrated by quenching of intrinsic tryptophan fluorescence and chemical modification studies. Quenching of fluorescence of the sole tryptophan residue, Trp 80, by poly(U), KI, and CsCl indicates that the microenvironment of this residue is more positive in pp12 than in p12. Chemical modification studies indicate that the 3 lysine residues at positions 36, 37, and 39 of pp12 react with 2,4,6-trinitrobenzenesulfonic acid, while only 1 of these residues reacts in p12. The addition of single-stranded, but not double-stranded RNA, to pp12 protects 2 of the 3 lysine residues from chemical modification, suggesting that the two protected lysyl groups are required for binding to single-stranded viral RNA. In contrast to the phosphorylation of serine 40, phosphorylation of serine 43, catalyzed by protease-activated kinase II in vitro, does not induce changes in the protein conformation nor does it alter the RNA binding properties of the protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991270

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

2.  Role of the gag polyprotein precursor in packaging and maturation of Rous sarcoma virus genomic RNA.

Authors:  S Oertle; P F Spahr
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging.

Authors:  C Méric; P F Spahr
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

4.  Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes.

Authors:  C Méric; E Gouilloud; P F Spahr
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

5.  Binding and repression of translation of the cognate mRNA by Trichinella spiralis thymidylate synthase differ from the corresponding interactions of the human enzyme.

Authors:  Joanna Cieśla; Elzbieta Jagielska; Tomasz Skopiński; Magdalena D Abrowska; Frank Maley; Wojciech Rode
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

6.  The major site of phosphorylation within the Rous sarcoma virus MA protein is not required for replication.

Authors:  T D Nelle; M F Verderame; J Leis; J W Wills
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  Cauliflower mosaic virus coat protein is phosphorylated in vitro by a virion-associated protein kinase.

Authors:  J Martinez-Izquierdo; T Hohn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

8.  Conserved cysteine and histidine residues of the avian myeloblastosis virus nucleocapsid protein are essential for viral replication but are not "zinc-binding fingers".

Authors:  J E Jentoft; L M Smith; X D Fu; M Johnson; J Leis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

9.  Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein.

Authors:  P Dupraz; S Oertle; C Meric; P Damay; P F Spahr
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.